Last reviewed · How we verify
Lysobact Complete Sprey
Lysobact Complete Sprey is a broad-spectrum antibiotic spray.
Lysobact Complete Sprey is a broad-spectrum antibiotic spray. Used for Treatment of various skin and soft tissue infections.
At a glance
| Generic name | Lysobact Complete Sprey |
|---|---|
| Sponsor | Bosnalijek D.D |
| Drug class | Antibiotic |
| Modality | Small molecule |
| Therapeutic area | Infectious Diseases |
| Phase | Phase 3 |
Mechanism of action
It contains a combination of antibiotics that work together to combat various bacterial infections. The exact mechanism of action is not well-documented, but it is believed to inhibit bacterial cell wall synthesis and interfere with protein synthesis.
Approved indications
- Treatment of various skin and soft tissue infections
Common side effects
- Skin irritation
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lysobact Complete Sprey CI brief — competitive landscape report
- Lysobact Complete Sprey updates RSS · CI watch RSS
- Bosnalijek D.D portfolio CI